Creative Biosciences
About:
Creative Biosciences is a biomedical technology company.
Website: http://www.kangliming.com/
Top Investors: Alibaba Group, Agricultural Bank of China, CDH Investments, IDG Capital, Co-Stone Venture Capital
Description:
Kang Liming Bio is a biomedical technology company that specializes in the development, production and sales of tumor screening diagnostic products such as colorectal cancer fecal non-invasive screening kits.
Total Funding Amount:
$231M
Estimated Revenue Range:
$100M to $500M
Headquarters Location:
Guangzhou, Guangdong, China
Founded Date:
2015-01-01
Contact Email:
service(AT)creativebio.cn
Founders:
Zouhong Zhi
Number of Employees:
11-50
Last Funding Date:
2021-10-14
IPO Status:
Private
Industries:
© 2025 bioDAO.ai